These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23654079)

  • 21. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
    J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
    Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
    Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1/Th2 balance?
    Hoshimoto K; Ohta N; Ohkura T; Inaba N
    Gynecol Obstet Invest; 2000; 50(4):260-3. PubMed ID: 11093050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent changes of serum soluble CD30 concentration in children.
    Chrul S; Polakowska E
    Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
    Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
    Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical picture and treatment of 2212 patients with common variable immunodeficiency.
    Gathmann B; Mahlaoui N; ; Gérard L; Oksenhendler E; Warnatz K; Schulze I; Kindle G; Kuijpers TW; ; van Beem RT; Guzman D; Workman S; Soler-Palacín P; De Gracia J; Witte T; Schmidt RE; Litzman J; Hlavackova E; Thon V; Borte M; Borte S; Kumararatne D; Feighery C; Longhurst H; Helbert M; Szaflarska A; Sediva A; Belohradsky BH; Jones A; Baumann U; Meyts I; Kutukculer N; Wågström P; Galal NM; Roesler J; Farmaki E; Zinovieva N; Ciznar P; Papadopoulou-Alataki E; Bienemann K; Velbri S; Panahloo Z; Grimbacher B;
    J Allergy Clin Immunol; 2014 Jul; 134(1):116-26. PubMed ID: 24582312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications.
    Vodjgani M; Aghamohammadi A; Samadi M; Moin M; Hadjati J; Mirahmadian M; Parvaneh N; Salavati A; Abdollahzade S; Rezaei N; Srrafnejad A
    J Investig Allergol Clin Immunol; 2007; 17(5):321-8. PubMed ID: 17982925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.
    Ulusoy H; Kamanli A; Ilhan N; Kuru O; Arslan S; Alkan G; Ozgocmen S
    Rheumatol Int; 2012 Dec; 32(12):3857-62. PubMed ID: 22193227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.
    Boileau J; Mouillot G; Gérard L; Carmagnat M; Rabian C; Oksenhendler E; Pasquali JL; Korganow AS;
    J Autoimmun; 2011 Feb; 36(1):25-32. PubMed ID: 21075598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis.
    Ott H; Wilke J; Baron JM; Höger PH; Fölster-Holst R
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):395-402. PubMed ID: 19744181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
    Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
    Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
    Lin SJ; Chao HC; Chang KW; Yan DC
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency.
    Fevang B; Eugen-Olsen J; Yndestad A; Brosstad F; Beiske K; Aukrust P; Frøland SS
    Clin Immunol; 2009 Jun; 131(3):438-46. PubMed ID: 19232508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo.
    Fevang B; Yndestad A; Sandberg WJ; Holm AM; Müller F; Aukrust P; Frøland SS
    Clin Exp Immunol; 2007 Mar; 147(3):521-5. PubMed ID: 17302902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of zinc, iron and copper serum levels in patients with common variable immunodeficiency.
    Litzman J; Dastych M; Hegar P
    Allergol Immunopathol (Madr); 1995; 23(3):117-20. PubMed ID: 7572540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis.
    Rai AK; Thakur CP; Kumar P; Mitra DK
    Eur J Immunol; 2012 Oct; 42(10):2782-91. PubMed ID: 22806538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
    J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.